Cleveland BioLabs, Inc. (NASDAQ: CBLI), a drug discovery and development company, is engaged in developing treatments for cancer and the protection of normal tissues from radiation exposure and other stresses. The company is achieving this through leveraging its proprietary discoveries around programmed cell death. Cleveland BioLabs’ strategic partners include the Cleveland Clinic, ChemBridge Corporation, Roswell Park Cancer Institute and the Armed Forces Radiobiology Research Institute. For further information about Cleveland BioLabs, visit the company’s Web site at www.cbiolabs.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below: